Latest / Bloomberg Intelligence / SpaceX Is Said to Target $75 Billion in IPO at $135 Per Share

Transcript

SpaceX Is Said to Target $75 Billion in IPO at $135 Per Share · Bloomberg Intelligence

• 0:02
  Speaker 1: Bloomberg Audio Studios, podcasts, radio news. You're listening to the
• 0:10
  Speaker 1: Bloomberg Intelligence podcast. Catch us live weekdays at ten am
• 0:14
  Speaker 1: Eastern on Apple, Cocklay and Android Auto with the Bloomberg
• 0:17
  Speaker 1: Business app. Listen on demand wherever you get your podcasts,
• 0:21
  Speaker 1: or watch us live on YouTube.
• 0:24
  Speaker 2: I think the schedule is for the SpaceX IPO roadchhow
• 0:28
  Speaker 2: to start tomorrow.
• 0:29
  Speaker 3: Haven't seen a schedule, but that's what I'm hearing that.
• 0:32
  Speaker 4: Yeah, but this IPO is kind of progressing unusually. Yes,
• 0:36
  Speaker 4: it's so mammoth and they, you know, the company can
• 0:39
  Speaker 4: kind of call the shots on everything. And our reporting
• 0:41
  Speaker 4: shows that SpaceX's offering shares at one hundred and.
• 0:44
  Speaker 3: Thirty five dollars each.
• 0:45
  Speaker 4: If it gets that Elon Musk's net worth would be
• 0:49
  Speaker 4: just shy of a trillion dollars. It put him at
• 0:52
  Speaker 4: nine hundred and eighty eight billion dollars.
• 0:53
  Speaker 3: All right, here's the problem.
• 0:54
  Speaker 2: If you're an investor looking at this ipo, you don't
• 0:56
  Speaker 2: have any research. There's no research from Wall Street except
• 0:59
  Speaker 2: for Bloomberg Intelligence. George Ferguson joins us here. He is
• 1:03
  Speaker 2: a senior aerospace as analyst at Bloomberg Intelligence. He's got
• 1:06
  Speaker 2: a monster primer research report on SpaceX, So if you
• 1:12
  Speaker 2: have access to the Bloomberg terminal, you could find it
• 1:14
  Speaker 2: there under the aerospace dashboard a bi go and it
• 1:19
  Speaker 2: tells you everything you need to know about this company
• 1:21
  Speaker 2: and how stacks up relative to the comps and kind
• 1:24
  Speaker 2: of the market opportunities and all that kind of stuff.
• 1:27
  Speaker 3: That's the research, and you won't get street research for
• 1:29
  Speaker 3: a while.
• 1:30
  Speaker 2: So this is it on Global Wall Street. George joins us. Now, George,
• 1:34
  Speaker 2: what do you think the message is going to be
• 1:36
  Speaker 2: from Elon and Company regarding this company? Because boyd, it
• 1:41
  Speaker 2: is an expansive company with an expansive vision.
• 1:45
  Speaker 3: What do you think the message is going to be.
• 1:47
  Speaker 5: Yeah, Look, I think it's all about AI in the
• 1:50
  Speaker 5: future and the optimal way to deliver it, right, And
• 1:53
  Speaker 5: so I think that the space business, the lift business,
• 1:57
  Speaker 5: really supporting that satellite constellation Stark, which is all about
• 2:01
  Speaker 5: communications between the Earth surface and low Earth orbit. I
• 2:05
  Speaker 5: think that's interesting, but it's not I think a huge
• 2:09
  Speaker 5: value proposition. Right, you're trying to you'll be competing with
• 2:12
  Speaker 5: terrestrial providers that I think can do much better in
• 2:16
  Speaker 5: populated centers. So I think the big, big big sort
• 2:20
  Speaker 5: of opportunity here would be if data centers are going
• 2:23
  Speaker 5: to work in space, and AI is a big thing
• 2:26
  Speaker 5: in the world, You're going to be able to from
• 2:28
  Speaker 5: the surface of the Earth shoot your data request into
• 2:31
  Speaker 5: space and data centers in space will work out all
• 2:35
  Speaker 5: those things you need to know via AI and get
• 2:37
  Speaker 5: it back to you. I think you're betting on that
• 2:39
  Speaker 5: in the long run if you're buying into this into
• 2:43
  Speaker 5: the space X IPO.
• 2:44
  Speaker 4: George, we talk about how your title is the aerospace,
• 2:46
  Speaker 4: defense and airlines analysts. What kind of company is SpaceX
• 2:50
  Speaker 4: now is what is the comparable company? What group should
• 2:55
  Speaker 4: be considered a peer to?
• 2:57
  Speaker 2: Yeah?
• 2:57
  Speaker 5: So I mean when we built our value, shouldn't thought
• 3:00
  Speaker 5: about what was potentially, you know, plausible given current markets.
• 3:07
  Speaker 5: We really had to do with some of the parts, right,
• 3:09
  Speaker 5: So I went out and looked at the rocket business
• 3:11
  Speaker 5: against those peers like rocket Lab. My colleagues John Butler
• 3:15
  Speaker 5: went out and looked at Starlink based on some peers
• 3:19
  Speaker 5: as well, and then Man Deep Sing did it based
• 3:22
  Speaker 5: on AI. The biggest value that actually came out of
• 3:25
  Speaker 5: Rocket Lab. So I came out of the rocket business,
• 3:28
  Speaker 5: which is a little bit surprising to me. But I
• 3:30
  Speaker 5: still think sort of the you know, the long term
• 3:33
  Speaker 5: play here is the data center in space and AI.
• 3:37
  Speaker 5: So but we had we had to combine again analysis
• 3:40
  Speaker 5: and all those industries to really come up with what
• 3:43
  Speaker 5: we thought maybe a plausible valuation, albeit extremely lofty valuation,
• 3:48
  Speaker 5: would be.
• 3:50
  Speaker 3: Is there an expectation, George, that.
• 3:53
  Speaker 2: Elon may look to just kind of consolidate all of
• 3:56
  Speaker 2: his holdings within SpaceX, i e.
• 3:59
  Speaker 3: Roll up Tesla into SpaceX.
• 4:00
  Speaker 2: Is that something that when you talk to investors that
• 4:03
  Speaker 2: they think is possible?
• 4:04
  Speaker 3: Likely?
• 4:06
  Speaker 5: I hear noise like that. I mean, look, I think,
• 4:09
  Speaker 5: you know, when I look at the current SpaceX I
• 4:13
  Speaker 5: see the reason to put these three companies together again.
• 4:16
  Speaker 5: Sort of, the launch business gets your satellite constellations up
• 4:20
  Speaker 5: in the air. He's got the largest satellite constellations. Starlink
• 4:23
  Speaker 5: by far is the largest of any satellite constellation lower
• 4:27
  Speaker 5: with orbit. So the launch business gets those satellites up there,
• 4:31
  Speaker 5: it serves Starlink. And then again as AI comes in,
• 4:35
  Speaker 5: if you're going to put the data centers in space,
• 4:37
  Speaker 5: you've got to drive down the cost of drive of
• 4:40
  Speaker 5: getting things into orbit. And again your launch business matters,
• 4:43
  Speaker 5: and you know, you obviously need communications to get to it.
• 4:46
  Speaker 5: So I see how all three of those fit together.
• 4:49
  Speaker 5: I don't see how Tesla fits inside that mold. Now, look,
• 4:53
  Speaker 5: I think these all three of these are together because
• 4:56
  Speaker 5: AI needs a fair amount of financing. Right now, we're
• 5:01
  Speaker 5: seeing that all around the marketplace, right AI companies are
• 5:03
  Speaker 5: looking to raise funds to build data centers, build out
• 5:07
  Speaker 5: their models, make sure they're super competitive. So so look,
• 5:11
  Speaker 5: I think Elon could do. You could see him do
• 5:14
  Speaker 5: things for financing reasons that may not make sense from
• 5:20
  Speaker 5: you know, a company level reason. Right now, I see
• 5:22
  Speaker 5: the reason these three are together because they seem to
• 5:25
  Speaker 5: be supporting each other.
• 5:26
  Speaker 4: So, George, when SpaceX is a publicly traded company listed
• 5:30
  Speaker 4: on the NASAC under the CHICK or spc X and
• 5:32
  Speaker 4: it needs more money to fund its AI build out,
• 5:35
  Speaker 4: how's it going to get that money?
• 5:36
  Speaker 3: Is it going to sell more stock? Is it going
• 5:38
  Speaker 3: to go to the debt market? What are you thinking?
• 5:41
  Speaker 5: Well, I mean, right now, they're not selling all the
• 5:43
  Speaker 5: all the stock, you know they're they're not. They're not
• 5:46
  Speaker 5: listing sort of the full value this company on the exchanges.
• 5:50
  Speaker 2: Uh.
• 5:51
  Speaker 5: But but so so my sense is they probably could
• 5:55
  Speaker 5: sell more stock to raise money. Uh, and then I
• 5:58
  Speaker 5: think it's just, you know, it opened up the ability
• 6:01
  Speaker 5: to go into public markets and take public debt and
• 6:05
  Speaker 5: sort of I guess maybe get out of the venture
• 6:07
  Speaker 5: capital world a little bit. But look, I mean, I
• 6:13
  Speaker 5: guess we'll see. It still seems like a really hard
• 6:16
  Speaker 5: It's not a company that you're going to bank, right
• 6:18
  Speaker 5: the major banks of the world are going to show
• 6:20
  Speaker 5: up and say, we like the financi of the metrics
• 6:22
  Speaker 5: just aren't there for that some very specuative you know,
• 6:26
  Speaker 5: bond investors could potentially get involved. It still feels like
• 6:30
  Speaker 5: largely and you know, an equity fundraising kind of story
• 6:34
  Speaker 5: to make.
• 6:35
  Speaker 3: Stay with us. More from Bloomberg Intelligence coming up after this.
• 6:42
  Speaker 1: You're listening to the Bloomberg Intelligence podcast. Catch us live
• 6:45
  Speaker 1: weekdays at ten am Eastern on Apple, cock Play and
• 6:48
  Speaker 1: Android Auto with the Bloomberg Business app. Listen on demand
• 6:51
  Speaker 1: wherever you get your podcasts, or watch us live on YouTube.
• 6:56
  Speaker 4: We continue to look for details on this gigantic IPO
• 6:59
  Speaker 4: coming out from SpaceX. The latest reporting indicates that the
• 7:03
  Speaker 4: company plans to offer shares at one hundred and thirty
• 7:05
  Speaker 4: five dollars a piece that wants to raise seventy five
• 7:08
  Speaker 4: billion dollars in its IPO. And you know the fact
• 7:11
  Speaker 4: that it's kind of pinpointed a price already makes it
• 7:14
  Speaker 4: different than your typical IPO where companies announce a price
• 7:18
  Speaker 4: range as they get ready to market the shares during
• 7:21
  Speaker 4: these investor road shows. Let's bring in Godamakunda. He is
• 7:24
  Speaker 4: a lecturer at the Yale School of Management. He's also
• 7:26
  Speaker 4: a contributor to Bloomberg Opinion, and he's written about governance
• 7:30
  Speaker 4: at SpaceX, or perhaps lack of governance at SpaceX, and
• 7:33
  Speaker 4: got him. I want to start with this idea that
• 7:36
  Speaker 4: SpaceX's IPO is shaping them to be kind of a
• 7:38
  Speaker 4: departure from the norm. And you say that that's the
• 7:41
  Speaker 4: case with its governance as well, what have you spotted
• 7:44
  Speaker 4: in the paperwork that is filed that really shows its
• 7:46
  Speaker 4: defying convention.
• 7:49
  Speaker 6: They basically surrounded Elon Musk with rights and privileges and
• 7:53
  Speaker 6: special voting shares and rules and things like that that
• 7:56
  Speaker 6: make him. You know, the phrase I used in the
• 7:57
  Speaker 6: column was he's now the god king of like he
• 8:00
  Speaker 6: can never be fired. He has total control. No one
• 8:03
  Speaker 6: the organization has any ability to put a brake on him,
• 8:05
  Speaker 6: no shareholders the anability to put a break on him.
• 8:09
  Speaker 6: A lot of CEOs have been doing a lot to
• 8:11
  Speaker 6: concentrate power in their own hands, but I don't think
• 8:13
  Speaker 6: I've ever seen anything quite.
• 8:14
  Speaker 3: Like this Gotham.
• 8:16
  Speaker 2: It kind of makes sense, my guess, if I were
• 8:18
  Speaker 2: an investor taking a meeting here for this IPL, all
• 8:21
  Speaker 2: I want to hear is from Elon Musk and what
• 8:23
  Speaker 2: his vision is and how he thinks he can get
• 8:25
  Speaker 2: there and get chief profitability.
• 8:26
  Speaker 3: I don't care what the CFO says, I don't care
• 8:28
  Speaker 3: what anybody else says.
• 8:28
  Speaker 2: I just need to dial in on Elon because it's
• 8:31
  Speaker 2: a bet on Elon.
• 8:32
  Speaker 3: Maybe that's not reflected in the governance. No, I think
• 8:35
  Speaker 3: that's right.
• 8:36
  Speaker 6: And look, if you are, you know, a major institutional
• 8:39
  Speaker 6: investor and you decide to go in on SpaceX, you
• 8:41
  Speaker 6: do it because you are bought in on the story
• 8:43
  Speaker 6: of Elon Musk, and you might have lots of reasons
• 8:45
  Speaker 6: to buy it on that.
• 8:46
  Speaker 3: You might have made a lot of money on him.
• 8:48
  Speaker 6: There are two problems with that logic, and it's important
• 8:51
  Speaker 6: to help to highlight both of them. The first one
• 8:54
  Speaker 6: is a lot of the people who are investing in
• 8:55
  Speaker 6: SpaceX are not people who are buying into into the
• 8:58
  Speaker 6: logic the story of Elon Musk, their index fund people
• 9:01
  Speaker 6: who hold index funds, people in their four O one
• 9:03
  Speaker 6: ks who are just going in because it's in the index.
• 9:06
  Speaker 6: And because all of these institutions from you know, including
• 9:09
  Speaker 6: NASDAK that are supposed to put boundaries and guardrails and
• 9:13
  Speaker 6: protect instant investors like that, investors who because they're in
• 9:17
  Speaker 6: index funds literally cannot protect themselves. All of them have
• 9:20
  Speaker 6: fallen down on the job and decided that they're not
• 9:22
  Speaker 6: going to do that. So that's the first problem. But
• 9:24
  Speaker 6: the second problem, which it is just as important, which is,
• 9:27
  Speaker 6: however brilliant you think Elon Musk is, what, even if
• 9:31
  Speaker 6: you think he is the greatest business person who's ever lived,
• 9:33
  Speaker 6: there's no such thing as as a person who is
• 9:36
  Speaker 6: so brilliant they don't get better when other people test
• 9:39
  Speaker 6: and push their ideas. And this is a structure that's
• 9:42
  Speaker 6: designed to make sure that no one has the ability
• 9:45
  Speaker 6: to force Elon Musk to be the best version of
• 9:47
  Speaker 6: himself and not the worst one.
• 9:49
  Speaker 4: Well, I mean, SpaceX is not unusual in that it's
• 9:52
  Speaker 4: giving its some you know, leader of free hand you
• 9:55
  Speaker 4: point this out that Google's two thousand and four IPO
• 9:58
  Speaker 4: kind of codify this dual class shares into the tech
• 10:02
  Speaker 4: industry meta or then Facebook did something similar, So in
• 10:05
  Speaker 4: that way, this is a tried and true formula for
• 10:08
  Speaker 4: big tech companies.
• 10:11
  Speaker 6: Yes, and no, there's a great phrase in medicine that's
• 10:13
  Speaker 6: worth remembering here, the dose makes the poison. A lot
• 10:17
  Speaker 6: of companies did this. They created these dual class structures.
• 10:21
  Speaker 6: They did a lot of things because the financial markets
• 10:24
  Speaker 6: and sort of pressure from in Wall Street had made
• 10:27
  Speaker 6: it impossible for them to manage companies for the long term.
• 10:30
  Speaker 6: They realized that that was toxic. They looked, say at Boeing,
• 10:33
  Speaker 6: and said, we don't want to be Boeing, We don't
• 10:35
  Speaker 6: want to be ge We want to be a company
• 10:37
  Speaker 6: that actually creates value over the long term. And so
• 10:40
  Speaker 6: they created these structures to allow that to happen. That
• 10:44
  Speaker 6: was the problem. We have now taken this to the
• 10:46
  Speaker 6: point where the solution looks in a very great sense
• 10:49
  Speaker 6: to be much worse than the problem.
• 10:51
  Speaker 3: So thirty seconds left, Baltham, are you the index issue?
• 10:56
  Speaker 3: How serious is that for investors? Do you think?
• 10:59
  Speaker 6: I think it's in the So in this particular stock.
• 11:02
  Speaker 6: It is not devastating, although it's not good. What it's
• 11:05
  Speaker 6: those very serious our investors, is it is an assault
• 11:08
  Speaker 6: on the integrity of the capital markets, the guarantee that
• 11:10
  Speaker 6: you will be treated fairly, that this is not just
• 11:13
  Speaker 6: a way for insiders to extract money from index investors
• 11:17
  Speaker 6: and from people from people or not who are not,
• 11:19
  Speaker 6: you know, sort of asphiscated as they are right now.
• 11:22
  Speaker 6: This is structured as a transfer of wealth from like
• 11:25
  Speaker 6: investors to early stage space ex holders. That's wrong, and
• 11:29
  Speaker 6: it's that it is. It is really a frontal assault
• 11:32
  Speaker 6: on the thing one of the pillars of American capitalism
• 11:36
  Speaker 6: that has made it so successful.
• 11:39
  Speaker 3: Stay with us.
• 11:40
  Speaker 4: More from Bloomberg Intelligence coming up after this.
• 11:44
  Speaker 1: You're listening to the Bloomberg Intelligence podcast. Catch us live
• 11:48
  Speaker 1: weekdays at ten am Eastern on Apple, Cocklay and Android
• 11:51
  Speaker 1: Auto with the Bloomberg Business App. Listen on demand wherever
• 11:54
  Speaker 1: you get your podcasts, or watch us live on YouTube.
• 11:58
  Speaker 2: Let me take you all the way back to this
• 12:00
  Speaker 2: summer of nineteen ninety one. I was in the Chase
• 12:02
  Speaker 2: Manhattan Bank Summer that credit training program, and we were
• 12:06
  Speaker 2: assigned a company do a full credit report on and
• 12:08
  Speaker 2: do a presentation. That company for me was Medtronic medical
• 12:13
  Speaker 2: device maker. So I followed the company kind of ever since,
• 12:15
  Speaker 2: because when you put in a ton of work on
• 12:17
  Speaker 2: a company, it tends to stick in your brain. Other
• 12:19
  Speaker 2: folks cover the stock as well. They reported some numbers.
• 12:21
  Speaker 2: I thought that looked pretty decent to me. The stock
• 12:23
  Speaker 2: is up five percent today, but it's down about nineteen
• 12:25
  Speaker 2: percent year to date. This is one of the leading
• 12:27
  Speaker 2: medical device makers out there, so let's pay attention to
• 12:29
  Speaker 2: what's happening there. Matt Hendrickson does. He's a senior ecadanas
• 12:32
  Speaker 2: Bloomberg Intelligence, joining us live here in our studio.
• 12:35
  Speaker 3: Here, Matt talk to us about met Metronic.
• 12:37
  Speaker 2: What do you hear from them in their earnings releasing?
• 12:39
  Speaker 7: Yeah, I mean so, going in ahead of the call,
• 12:41
  Speaker 7: the question was for one of their key technologies, whether
• 12:45
  Speaker 7: it was a market slowdown or a competitive dynamic. The
• 12:48
  Speaker 7: previous company reporting, Boston Scientific talked about slow down, turned
• 12:53
  Speaker 7: into what was going to happen? When Metronic reported, they
• 12:56
  Speaker 7: reported very positive one hundred and twenty four percent growth
• 12:59
  Speaker 7: in this one secondment.
• 13:02
  Speaker 8: Eased a lot of concern ahead of the call. That's
• 13:04
  Speaker 8: why you're.
• 13:04
  Speaker 7: Seeing the bump this morning, right, and so turning into
• 13:07
  Speaker 7: their fiscal twenty twenty seven guidance shows signs of upside
• 13:11
  Speaker 7: in the future because of that momentum in that segment.
• 13:15
  Speaker 2: A medical device maker like Metronic, how much how much
• 13:18
  Speaker 2: are they impacted by healthcare policy out there? It seems
• 13:22
  Speaker 2: like it's such a a You guys have to figure
• 13:23
  Speaker 2: out what the earning is going to be and all
• 13:25
  Speaker 2: that kind of stuff, and Josto have to have an
• 13:26
  Speaker 2: opinion on it and of how policy is gonna unveil
• 13:29
  Speaker 2: over the next several years.
• 13:30
  Speaker 8: Yeah, it's it's it's tough. It's always a labyrinth.
• 13:33
  Speaker 7: It's a black box what's going on in the CMS
• 13:35
  Speaker 7: and the FBA. Medtech is a little bit less impacted
• 13:42
  Speaker 7: by it. You're gonna have procedure volumes, you have the
• 13:44
  Speaker 7: aging demographic, They're gonna have me procedures done. They're gonna
• 13:47
  Speaker 7: have heart surgery done, things like that. Recently, it's more
• 13:51
  Speaker 7: been the g LPs and so I remember two three
• 13:55
  Speaker 7: years ago when glp's first came out, everyone thought medtech
• 13:58
  Speaker 7: was dead. They were able totain procedure volumes. Now, with
• 14:01
  Speaker 7: the rise of oral glps, that is kind of coming back.
• 14:04
  Speaker 3: So what's the thinking there, what's the thesis.
• 14:07
  Speaker 7: Basically, it's easier to take a GLP orally as a
• 14:11
  Speaker 7: pill versus injecting.
• 14:12
  Speaker 3: Yourself for all the fewer knee replaces.
• 14:15
  Speaker 7: There's there's there's data out there that's showing that it's
• 14:18
  Speaker 7: it aids with cardiovascular cases, things like you know, healthier knees,
• 14:24
  Speaker 7: things like that, So less procedures there. What we saw
• 14:28
  Speaker 7: in twenty twenty four twenty twenty five is that cases
• 14:30
  Speaker 7: were steady throughout the whole and if not growing interesting
• 14:34
  Speaker 7: but once again we're getting into that new case of
• 14:36
  Speaker 7: uncertainty going on.
• 14:38
  Speaker 2: I was talking to Buddy Mind. He's that the doctor
• 14:40
  Speaker 2: that fixes his knees and ankles and stuff like that.
• 14:42
  Speaker 2: It's just pick aball has been a boon to his business.
• 14:45
  Speaker 2: His office is packed with people my age coming in
• 14:48
  Speaker 2: with torn up knees and ankles because they're playing pickleball.
• 14:51
  Speaker 8: You're you're not the first one to say that, because
• 14:53
  Speaker 8: I mean, think about it.
• 14:54
  Speaker 7: They're just so they're so eager to get out there
• 14:56
  Speaker 7: and they forget that they're in there's sixties and seventies
• 14:59
  Speaker 7: and next thing you know, crack. And then got to
• 15:02
  Speaker 7: get to the surgeon.
• 15:03
  Speaker 2: So who does Metronic compete against in their business?
• 15:07
  Speaker 7: So well, Metronics is very diversified, and so we can
• 15:09
  Speaker 7: talk about the cardiovascular space, the spine space, neuroscience for
• 15:14
  Speaker 7: particular this case pulse field ablation, which was not there
• 15:18
  Speaker 7: in nineteen ninety one. It's a new technology for cardiac ablation.
• 15:23
  Speaker 7: The two main competitors is Boston Scientific and Metronic. And
• 15:27
  Speaker 7: it turned into that question when Boston reported growth numbers
• 15:31
  Speaker 7: that were lower than expected, what was going to happen
• 15:34
  Speaker 7: to Medtronic? And so today was a kind of a
• 15:36
  Speaker 7: clear that hurdle at.
• 15:37
  Speaker 2: Least did these medical device companies like Metronic? Are they
• 15:42
  Speaker 2: aggressive on the acquisition front? Is that a growth driver
• 15:45
  Speaker 2: for them? Because I always joke with Sam Fazzelli his
• 15:47
  Speaker 2: pharma companies, every Monday morning, we wake up, there's another
• 15:49
  Speaker 2: farm of deal.
• 15:50
  Speaker 7: It's a it's a huge way for them to drive
• 15:52
  Speaker 7: that innovation that basically they acquire the innovation to be
• 15:55
  Speaker 7: able to maintain their revenue growth trajectory in the future.
• 16:00
  Speaker 8: So it's huge.
• 16:01
  Speaker 7: The difference that we're starting to see in medtech side
• 16:04
  Speaker 7: versus the pharmacide is that they're targeting the private companies
• 16:08
  Speaker 7: earlier in their series financing before they become publicly traded.
• 16:13
  Speaker 7: While Sam was probably talking about a lot of the
• 16:15
  Speaker 7: publicly traded companies that have been acquired over the last
• 16:18
  Speaker 7: few months.
• 16:19
  Speaker 2: So what's the call on Medtronic here? I'm just looking
• 16:23
  Speaker 2: at the an R function on the Bloomberg terminal. It's
• 16:26
  Speaker 2: kind of streets kind of split here. I got seventeen
• 16:28
  Speaker 2: buys but fourteen holds here. So what's kind of the
• 16:32
  Speaker 2: Is there something Streets looking for to say, Okay, I
• 16:34
  Speaker 2: can jump on board here.
• 16:35
  Speaker 8: I think people are waiting for.
• 16:37
  Speaker 7: It's always been an execution story for Medtronic, and it's
• 16:39
  Speaker 7: always been kind of Lucy pulling the football from you,
• 16:42
  Speaker 7: and they would have one or two great quarters. They
• 16:44
  Speaker 7: always talked about the great innovation, and the innovation always
• 16:47
  Speaker 7: has been promising for you know, whether it's pulse field ablation.
• 16:51
  Speaker 7: There's a few other ones that we can go into
• 16:53
  Speaker 7: the nitty gritties of it at another time. But all
• 16:55
  Speaker 7: this technology that is disrupting the standard of care, but
• 16:58
  Speaker 7: for whatever reason, the sales team or just the execution
• 17:01
  Speaker 7: wasn't there, So they would always have to revise something
• 17:03
  Speaker 7: after the third quarter, and then things would then retrace
• 17:07
  Speaker 7: from those kind of momentum that they had earlier. It's
• 17:11
  Speaker 7: kind of so basically there is that a little bit
• 17:13
  Speaker 7: of I don't want the some that I don't want
• 17:16
  Speaker 7: to try to kick the football for Lucy just to
• 17:17
  Speaker 7: pull it from me.
• 17:18
  Speaker 3: Yep.
• 17:19
  Speaker 8: And so they've had a bunch of good quarters.
• 17:21
  Speaker 7: It's going into you know, they issued fiscal twenty twenty
• 17:24
  Speaker 7: seven guidance that's showing that momentum from fiscal twenty twenty six.
• 17:29
  Speaker 7: A lot of it has to do with the Polsfield
• 17:31
  Speaker 7: ablation segment of their business that's showing some strong momentum.
• 17:36
  Speaker 7: So we'll see what happens come August with the fiscal
• 17:38
  Speaker 7: first quarter calls coming out.
• 17:40
  Speaker 4: Stay with us more from Bloomberg Intelligence coming up after this.
• 17:47
  Speaker 1: You're listening to the Bloomberg Intelligence podcast. Catch us Live
• 17:51
  Speaker 1: weekdays at ten am Eastern on Apple Coarclay, and Android
• 17:54
  Speaker 1: Auto with the Bloomberg Business app. Listen on demand wherever
• 17:58
  Speaker 1: you get your podcasts, or what us Live on YouTube.
• 18:02
  Speaker 2: In terms of earnings, Macy's reported some pretty good numbers.
• 18:05
  Speaker 2: Stocks trading up here today one and a half percent.
• 18:07
  Speaker 2: Let's break it down with Mary Ross Gilbert. She covers
• 18:09
  Speaker 2: the retailers for Bloomberg Intelligence. She's based out there in
• 18:13
  Speaker 2: Los Angeles.
• 18:15
  Speaker 3: So, Mary, what do we hear from Macy's.
• 18:18
  Speaker 9: Well, what you're hearing from Macy's, Paul, is that they're executing.
• 18:22
  Speaker 9: That's what you're hearing. So what we saw on the quarter,
• 18:25
  Speaker 9: their comps were up three percent. We had very strong
• 18:28
  Speaker 9: gains from Bloomingdale's being up ten percent. And what the
• 18:32
  Speaker 9: company is doing is they're bringing in a lot more
• 18:35
  Speaker 9: relevant brands. First of all, they had already been executing
• 18:38
  Speaker 9: it Bloomingdale's, but they're even taking it to a next level.
• 18:42
  Speaker 9: So I think I mentioned before last quarter how they
• 18:45
  Speaker 9: brought in our local store here in Westfield Century City.
• 18:49
  Speaker 9: They brought in a Chanelle shoe boutique that was brought
• 18:53
  Speaker 9: in over a year ago, and then just this year
• 18:56
  Speaker 9: they brought in Christian Lubaton. Well in New York City
• 19:00
  Speaker 9: in the fifty ninth Strength Street location, they have a
• 19:03
  Speaker 9: praduct shoe boutique. So what they're doing is just continuing
• 19:07
  Speaker 9: to elevate. This is also happening on the macy side too,
• 19:10
  Speaker 9: where they're really climbing up in terms of the brands
• 19:14
  Speaker 9: that they're bringing in. So some of the brands that
• 19:16
  Speaker 9: they mentioned include Mango is one of them. They're also
• 19:22
  Speaker 9: doing a whole activation for World Cup with Nike Audidos
• 19:27
  Speaker 9: and also Puma. So very exciting things that the company
• 19:32
  Speaker 9: is doing. And if you look online at their website,
• 19:35
  Speaker 9: it has completely changed. It's a lot more engaging, it's
• 19:39
  Speaker 9: a lot more exciting. So they're really and there's more
• 19:43
  Speaker 9: to come. So even with the nice game that we
• 19:46
  Speaker 9: saw this quarter, I think we're going to continue to
• 19:49
  Speaker 9: see that momentum build.
• 19:50
  Speaker 4: And Jessa heads up to everyone that Macy COEO Tony
• 19:53
  Speaker 4: Springwomb will be on Bloomberg Television today live at four
• 19:56
  Speaker 4: thirty pm speaking with Romaine Bostik, so we can get
• 20:00
  Speaker 4: more detail from the CEO. And I bring that up
• 20:03
  Speaker 4: because I feel like Macy's, the company, Bloomingdale's in particular,
• 20:08
  Speaker 4: was definitely a winner here. Following the bankruptcy filing of
• 20:11
  Speaker 4: SAX Global Enterprises, the parent company of SAX Fifth Avenue,
• 20:15
  Speaker 4: which has had to shut down a lot of stores.
• 20:18
  Speaker 8: Is that the case?
• 20:20
  Speaker 9: It absolutely is the case, Scarlet. We've been noticing this
• 20:23
  Speaker 9: and it actually really started last year and we saw
• 20:27
  Speaker 9: the sharp acceleration in Bloomingdale's sales ahead of the bankruptcy
• 20:31
  Speaker 9: actually because of the miss execution that was going on
• 20:36
  Speaker 9: when they acquired Nieman Marcus, and Nieman Marcus, which had
• 20:39
  Speaker 9: been showing positive sales trend, turned sharply negative following that acquisition.
• 20:45
  Speaker 9: So you can see that the consolidated chain, they weren't
• 20:48
  Speaker 9: paying vendors, they weren't treating their customers. While not accepting returns,
• 20:53
  Speaker 9: they couldn't get a lot of these customers who were
• 20:56
  Speaker 9: frustrated couldn't get in touch with anyone. So meanwhile, while
• 21:00
  Speaker 9: Bloomingdale's was really elevating their execution, they're taking share essentially.
• 21:06
  Speaker 9: And so I think we're continuing to see that because
• 21:08
  Speaker 9: even if we look at the transaction data, we can
• 21:11
  Speaker 9: see that the sales are still down double digits at
• 21:15
  Speaker 9: the consolidated Nieman Marcus group. So so the SAX global When.
• 21:21
  Speaker 2: You talk to your retailers, are they trying to go
• 21:24
  Speaker 2: just generally more upscale. I'm thinking about this case case
• 21:29
  Speaker 2: shaped economy, and the parts of the case seem to
• 21:32
  Speaker 2: be getting more and more pronounced. So if you're Macy's,
• 21:35
  Speaker 2: maybe on the margin I go a little higher end.
• 21:37
  Speaker 2: That brings some brands into maybe I wouldn't have had
• 21:39
  Speaker 2: them to pass.
• 21:39
  Speaker 3: Are you hearing that?
• 21:41
  Speaker 9: We're absolutely hearing that to a certain extent, though, Paul,
• 21:45
  Speaker 9: you raise a valid question. It's also important that you
• 21:49
  Speaker 9: have those entry brands, and you saw this with Cohle's.
• 21:52
  Speaker 9: That's really where their focus is because their consumer is
• 21:56
  Speaker 9: really that lower income that's our core consumer. Macy's will say,
• 22:00
  Speaker 9: our core consumer is really middle income to upper income,
• 22:05
  Speaker 9: and so they have to make sure they have sort
• 22:08
  Speaker 9: of those entry levels. So it's called really the good, better,
• 22:12
  Speaker 9: and best classifications. But yes, they're really pushing their merchants
• 22:18
  Speaker 9: to focus on going up the best chain because they're
• 22:22
  Speaker 9: finding that having newness.
• 22:25
  Speaker 3: Will drive conversion.
• 22:27
  Speaker 9: So bringing in new, fresh, exciting brands and classifications are
• 22:32
  Speaker 9: really driving that that incremental sales gain. And their average
• 22:38
  Speaker 9: price was up eight point three percent, so you had
• 22:41
  Speaker 9: at the Bloomingdale side it was up about nine to
• 22:43
  Speaker 9: ten percent, but Macy's the name plate was up mid
• 22:47
  Speaker 9: single digits, and where they saw strength and beauty once
• 22:50
  Speaker 9: again driven by a lot of newness across skincare and
• 22:54
  Speaker 9: fragrance driving those gains there. So that really does make
• 22:57
  Speaker 9: a difference, but it is important to have that good, better,
• 23:00
  Speaker 9: and best classifications, not just in private labels. So they're
• 23:05
  Speaker 9: bringing in some of these entry level brands you know,
• 23:08
  Speaker 9: or extending those like a Sam Edelman for example.
• 23:12
  Speaker 1: This is the Bloomberg Intelligence podcast, available on Apple, Spotify,
• 23:17
  Speaker 1: and anywhere else you get your podcasts. Listen live each
• 23:20
  Speaker 1: weekday ten am to noon Eastern on Bloomberg dot com,
• 23:24
  Speaker 1: the iHeartRadio app, tune In, and the Bloomberg Business app.
• 23:28
  Speaker 1: You can also watch us live every weekday on YouTube
• 23:32
  Speaker 1: and always on the Bloomberg terminal